Paul Mitchell

机构：The University of Sydney, Austin Hospital, Westmead Hospital, Sydney Local Health District, Westmead Institute for Medical Research, Olivia Newton-John Cancer Wellness & Research Centre, Austin Health, Olivia Newton-John Cancer Research Institute · ORCID：0000-0003-2470-3790

发表论文 556 篇 · 总被引 34650 次 · h-index 91

代表论文

• Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials (2023 · The Lancet · 被引 503)
• Hypertensive retinopathy and cardiovascular disease risk: 6 population-based cohorts meta-analysis (2023 · International Journal of Cardiology Cardiovascular Risk and Prevention · 被引 21)
• Dexamethasone intravitreal implant in diabetic macular oedema refractory to anti-vascular endothelial growth factors: the AUSSIEDEX study (2023 · BMJ Open Ophthalmology · 被引 19)
• Efficacy and safety of sunvozertinib in treatment naïve NSCLC patients with EGFR exon20 insertion mutations. (2023 · Journal of Clinical Oncology · 被引 15)
• 1325P Sunvozertinib as first-line treatment in NSCLC patients with EGFR Exon20 insertion mutations (2023 · Annals of Oncology · 被引 14)
• Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration (2024 · Ophthalmology and Therapy · 被引 8)